Please Wait

Applying Filters...

FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Calcipotriol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

49 API Suppliers, 19 USDMF, 11 CEP/COS, 4 EU WC, 1 KDMF, 12 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

49 Drugs in Development

49 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

298 FDF Dossiers, 23 FDA Orange Book, 229 Europe, 23 Canada, 10 Australia, 8 South Africa, 5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.005%, SOLUTION;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%, AEROSOL, FOAM;TOPICAL - 0.005%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Nanjing Well Pharmaceutical, 4 Kirsch Pharma, 3 Actylis, 12 BASF, 1 Corel Pharma Chem, 2 Finar, 1 Pluviaendo, 1 Seppic, 1 Symrise, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

19 Topical, 10 Parenteral, 6 Solubilizers, 5 Thickeners and Stabilizers, 4 Film Formers & Plasticizers, 4 Emulsifying Agents, 3 Lubricants & Glidants, 2 Granulation, 2 Direct Compression, 1 Controlled & Modified Release, 1 Fillers, Diluents & Binders, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

30 News #PharmaBuzz

30 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 29 Regulatory FDF Prices, 12 Annual Reports

MARKET PLACE

11 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

19 US Patents, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 Others

$ Xls

Filters

OINTMENT;TOPICAL - 0.064%;0.005%

SUSPENSION;TOPICAL - 0.064%;0.005%

CREAM;TOPICAL - 0.005%

SOLUTION;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, FOAM;TOPICAL - 0.005%

X

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Calcipotriol

Calcipotriol

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

49 API Suppliers

19 USDMF

11 CEP/COS

4 EU WC

1 KDMF

12 NDC API

23 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

49 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

298 FDF Dossiers

23 FDA Orange Book

229 Europe

23 Canada

10 Australia

8 South Africa

5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.005%

SOLUTION;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;TOPICAL - 0.064%;0.005%

SUSPENSION;TOPICAL - 0.064%;0.005%

AEROSOL, FOAM;TOPICAL - 0.005%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 Nanjing Well Pharmaceutical

4 Kirsch Pharma

3 Actylis

12 BASF

1 Corel Pharma Chem

2 Finar

1 Pluviaendo

1 Seppic

1 Symrise

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

19 Topical

10 Parenteral

6 Solubilizers

5 Thickeners and Stabilizers

4 Film Formers & Plasticizers

4 Emulsifying Agents

3 Lubricants & Glidants

2 Granulation

2 Direct Compression

1 Controlled & Modified Release

1 Fillers, Diluents & Binders

1 Surfactant & Foaming Agents

DIGITAL CONTENT

30 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions

29 Regulatory FDF Prices

12 Annual Reports

MARKET PLACE

11 APIs

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

19 US Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM

1 Others

Filters

SOLUTION;TOPICAL - 0.005% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons